Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Liz is Science Editor for Cancer Health, POZ, Hep and Real Health. She has been a health journalist and medical editor for more than 20 years, covering HIV, viral hepatitis, cancer and other health issues.
First-line treatment with immunotherapy and a chemotherapy regimen extended progression-free survival by 35%.
Vaccine development is proceeding at an unprecedented pace, but could still hit snags on the way to approval.
The vaccine from the University of Oxford and AstraZeneca uses a chimpanzee adenovirus vector.
The front-runner coronavirus vaccine appears to protect people from symptomatic disease.
Areas with lower population density have not seen the same slowdown as urban areas.
Adagrasib targets a specific cancer-causing mutation, while VS-6766 interferes with multiple steps in a cell growth signaling pathway.
Try to do at least 150 minutes of moderate-intensity physical activity every week.
Developing treatments for fatty liver disease has proved challenging, and there are currently no approved medications.
With appropriate precautions, voting in person carries little risk.
The starting age was lowered due to an increase in colorectal cancer among younger people.
Optimal treatment for fatty liver disease may involve combining drugs with different mechanisms of action.
The antiviral drug is the first treatment for the new coronavirus to be approved in United States.
A checkpoint inhibitor combination and an antibody-drug conjugate may offer new treatment options.
The best-performing combo, firsocostat and cilofexor, showed benefits despite missing the main study endpoint.
These three respiratory illnesses share many of the same symptoms.
None of the four drugs tested in the WHO’s Solidarity trial reduced mortality or duration of hospitalization.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.